BioCentury
ARTICLE | Distillery Therapeutics

Infectious disease

May 23, 2018 6:19 PM UTC

Patient sample and cell culture studies identified three broadly neutralizing antibodies (bNAbs) against HIV gp120 that could help treat the infection. Screening of neutralizing antibodies against HIV...

BCIQ Company Profiles

University of Maryland

BCIQ Target Profiles

HIV gp120